| Literature DB >> 29250438 |
Chen S Tsai1, Rong W Mao1, Shirley C Tsai2, Kaveh Shahverdi1, Yun Zhu1, Shih K Lin1, Yu-Hsiang Hsu3, Gerry Boss4, Matt Brenner5, Sari Mahon5, Gerald C Smaldone6.
Abstract
An in-depth review on a new ultrasonic micro-droplet generator which utilizes megahertz (MHz) Faraday waves excited by silicon-based multiple Fourier horn ultrasonic nozzles (MFHUNs) and its potential applications is presented. The new droplet generator has demonstrated capability for producing micro droplets of controllable size and size distribution and desirable throughput at very low electrical drive power. For comparison, the serious deficiencies of current commercial droplet generators (nebulizers) and the other ultrasonic droplet generators explored in recent years are first discussed. The architecture, working principle, simulation, and design of the multiple Fourier horns (MFH) in resonance aimed at the amplified longitudinal vibration amplitude on the end face of nozzle tip, and the fabrication and characterization of the nozzles are then described in detail. Subsequently, a linear theory on the temporal instability of Faraday waves on a liquid layer resting on the planar end face of the MFHUN and the detailed experimental verifications are presented. The linear theory serves to elucidate the dynamics of droplet ejection from the free liquid surface and predict the vibration amplitude onset threshold for droplet ejection and the droplet diameters. A battery-run pocket-size clogging-free integrated micro droplet generator realized using the MFHUN is then described. The subsequent report on the successful nebulization of a variety of commercial pulmonary medicines against common diseases and on the experimental antidote solutions to cyanide poisoning using the new droplet generator serves to support its imminent application to inhalation drug delivery.Entities:
Keywords: Faraday instability; Faraday waves; MFH ultrasonic nozzle; clogging free; integrated ultrasonic nebulizer; monodisperse; multiple Fourier horns (MFH); onset threshold for droplet ejection; polydisperse; pulmonary (inhalation) drug delivery; ultrasonic micro droplet generator; ultrasonic nebulizer
Year: 2017 PMID: 29250438 PMCID: PMC5726552 DOI: 10.3390/mi8020056
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
Figure 1Basic architectures of advanced commercial ultrasonic nebulizers: (a) active vibrating mesh with ring transducer; (b) passive screening mesh with disk transducer.
Figure 2(a) Classical planar geometry for Faraday wave formation at low drive frequency; (b) 3-D architecture of MHz 4-Fourier horn ultrasonic nozzle depicting the geometry of its end face and the liquid layer.
Figure 3(a) Layout of nozzles in an 8-inch silicon wafer; (b) MEMS-fabricated 1.0 and 2.0 MHz nozzles.
Figure 4Typical impedance curve of 2 MHz 4-Fourier horn nozzles.
Figure 5Rectangular coordinate system associated with liquid layer resting on the nozzle tip.
Figure 6Stability charts and vibration amplitude thresholds (critical displacement) for Faraday wave instability in the most unstable region (bounded by the two characteristic curves designated as ac1 and as1 in the legend) at the drive frequencies of 1.0, 1.5, and 2.0 MHz.
Figure 7Droplet ejection from a 60 µm-water layer on the end face (743 µm × 800 µm) of a 2.0 MHz 4-Fourier horn nozzle at 200 μL/min output rate and 0.15 W electrical drive power.
Figure 8Diameter and size distribution of (a) water droplets produced by a 2 MHz 4-Fourier horn nozzle; and (b) aerosols produced by an advanced commercial ultrasonic nebulizer operating at 180 kHz (Omron NE-U22V).
Figure 9Comparison between the measured droplet diameters and the theoretical predictions vs. drive frequency.
Figure 10Battery-run pocket-size integrated ultrasonic micro droplet generator with electronically controlled ON/OFF capability: (a) the stand-alone unit; (b) nebulization turned ON; (c) nebulization turned OFF; and (d) nebulization ON/OFF time scales.
Figure 11Particle deposition efficiency in human airways and lungs [25].
Summary of drugs nebulized using 2 MHz multiple Fourier horn ultrasonic nozzles except specified.
| Medicine | Medicine Concentration | Nebulizer Unit | Droplet MMD (µm) | Output Rate (µL/min) | Disease |
|---|---|---|---|---|---|
| Albuterol * | 25 mg/mL | Bench-scale | 4.5 | 150 | Asthma |
| Humulin, U100 * | 100 units/mL | Bench-scale | 4.5 | 100 | Diabetes |
| Cobinamide | 100 mM | Pocket-size | 3.7 | 150 | Cyanide poisoning |
| Magnesium thiosulfate | 1.0 M | Pocket-size | 3.8 | 150 | Sulfide poisoning |
| Interferon-γ | 100 µg/0.5 mL | Pocket-size | 2.9 | 100 | Pulmonary fibrosis |
| Budesonide suspension | 0.5 mg/2.0 mL | Pocket-size | 3.1 | 350 | Asthma |
* Ultrasonic drive frequency at 1 MHz; all medicines listed in the table are aqueous solutions (except budesonide suspension) with viscosities similar to water (~1 cP) except 1.3 cP for Cobinamide. In an earlier study [23], liquids with viscosity up to 4.5 cP were successfully nebulized.
Figure 12Battery-run pocket-size ultrasonic twin-nozzle nebulizer and twin-nozzle platform.